Alnylam Pharmaceuticals Announces Exercise of Over-Allotment Option in Public …
… Inc. /quotes/zigman/92224/quotes/nls/alny ALNY +14.30% , a leading RNAi therapeutics company, today announced that the underwriters of its previously announced public offering of common stock have exercised their option to purchase an additional …
See all stories on this topic »
